HealthEquity Price to Book Ratio 2014-2025 | HQY
Historical price to book ratio values for HealthEquity (HQY) over the last 10 years. The current price to book ratio for HealthEquity as of May 01, 2025 is 3.51.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| HealthEquity Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-05-01 | 87.95 | 3.60 | |
| 2025-01-31 | 110.42 | $24.44 | 4.52 |
| 2024-10-31 | 85.25 | $24.47 | 3.48 |
| 2024-07-31 | 78.48 | $24.70 | 3.18 |
| 2024-04-30 | 78.91 | $24.11 | 3.27 |
| 2024-01-31 | 75.58 | $23.63 | 3.20 |
| 2023-10-31 | 71.68 | $23.17 | 3.09 |
| 2023-07-31 | 67.94 | $22.77 | 2.98 |
| 2023-04-30 | 53.45 | $22.45 | 2.38 |
| 2023-01-31 | 60.85 | $22.37 | 2.72 |
| 2022-10-31 | 77.91 | $22.25 | 3.50 |
| 2022-07-31 | 58.17 | $22.06 | 2.64 |
| 2022-04-30 | 62.32 | $21.99 | 2.83 |
| 2022-01-31 | 53.44 | $22.11 | 2.42 |
| 2021-10-31 | 66.18 | $22.39 | 2.96 |
| 2021-07-31 | 73.98 | $22.28 | 3.32 |
| 2021-04-30 | 75.97 | $22.17 | 3.43 |
| 2021-01-31 | 83.55 | $17.87 | 4.68 |
| 2020-10-31 | 51.49 | $17.61 | 2.92 |
| 2020-07-31 | 51.56 | $17.44 | 2.96 |
| 2020-04-30 | 56.27 | $14.58 | 3.86 |
| 2020-01-31 | 66.06 | $14.50 | 4.56 |
| 2019-10-31 | 56.79 | $14.37 | 3.95 |
| 2019-07-31 | 81.98 | $14.40 | 5.69 |
| 2019-04-30 | 67.75 | $8.44 | 8.03 |
| 2019-01-31 | 62.34 | $7.64 | 8.16 |
| 2018-10-31 | 91.80 | $7.32 | 12.54 |
| 2018-07-31 | 75.50 | $6.95 | 10.86 |
| 2018-04-30 | 65.67 | $6.42 | 10.22 |
| 2018-01-31 | 50.62 | $5.69 | 8.89 |
| 2017-10-31 | 50.22 | $5.51 | 9.11 |
| 2017-07-31 | 45.87 | $5.23 | 8.77 |
| 2017-04-30 | 45.52 | $4.86 | 9.38 |
| 2017-01-31 | 46.25 | $4.40 | 10.51 |
| 2016-10-31 | 33.23 | $4.26 | 7.80 |
| 2016-07-31 | 29.52 | $4.09 | 7.21 |
| 2016-04-30 | 25.15 | $3.84 | 6.54 |
| 2016-01-31 | 21.55 | $3.52 | 6.11 |
| 2015-10-31 | 32.71 | $3.47 | 9.43 |
| 2015-07-31 | 33.66 | $3.34 | 10.07 |
| 2015-04-30 | 26.21 | $2.79 | 9.38 |
| 2015-01-31 | 20.77 | $2.63 | 7.90 |
| 2014-10-31 | 20.40 | $2.57 | 7.95 |
| 2014-07-31 | 17.60 | $0.91 | 19.34 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $7.414B | $1.200B |
| HealthEquity provides integrated solutions for health-care account management, health reimbursement arrangement and flexible spending accounts for health plans, insurance companies and third-party administrators in the United States. HealthEquity's flagship health savings account or HSA is a financial account through which consumers spend and save for the long term for healthcare on a tax-advantaged basis. This has provided the company with a competitive edge in the MedTech industry. Other than HSAs, the company offers Healthcare saving and spending platform, Investment platform and advisory services and Reimbursement arrangements. In addition, HealthEquity offers health reimbursement and flexible spending arrangements solutions; Employee Retirement Income Security Act's plan administration and investment services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $142.654B | 26.76 |
| Elevance Health (ELV) | United States | $95.024B | 12.26 |
| CVS Health (CVS) | United States | $84.108B | 12.31 |
| Cencora (COR) | United States | $56.754B | 20.60 |
| Natera (NTRA) | United States | $20.404B | 0.00 |
| DiDi Global (DIDIY) | China | $19.733B | 29.00 |
| BioMerieux (BMXMF) | France | $15.507B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.474B | 0.00 |
| ICON (ICLR) | Ireland | $12.230B | 11.37 |
| Solventum (SOLV) | United States | $11.439B | 10.66 |
| CochLear (CHEOY) | Australia | $11.362B | 0.00 |
| Revvity (RVTY) | United States | $11.225B | 18.95 |
| Doximity (DOCS) | United States | $10.619B | 55.22 |
| Viatris (VTRS) | United States | $10.051B | 3.18 |
| Medpace Holdings (MEDP) | United States | $8.864B | 23.54 |
| Avantor (AVTR) | United States | $8.852B | 12.86 |
| Sonic Healthcare (SKHHY) | Australia | $8.023B | 0.00 |
| Charles River Laboratories (CRL) | United States | $5.826B | 11.49 |
| Amplifon S.p.A (AMFPF) | Italy | $4.285B | 22.62 |
| Bausch + Lomb (BLCO) | Canada | $4.085B | 24.08 |
| Alignment Healthcare (ALHC) | United States | $3.503B | 0.00 |
| Organon (OGN) | United States | $3.361B | 3.39 |
| Sotera Health (SHC) | United States | $3.264B | 18.85 |
| BrightSpring Health Services (BTSG) | United States | $3.069B | 31.87 |
| Surgery Partners (SGRY) | United States | $2.814B | 32.28 |
| Concentras Parent (CON) | United States | $2.788B | 14.50 |
| Progyny (PGNY) | United States | $1.957B | 43.09 |
| GeneDx Holdings (WGS) | United States | $1.876B | 73.46 |
| Premier (PINC) | United States | $1.858B | 11.90 |
| Ardent Health Partners (ARDT) | United States | $1.817B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.776B | 38.58 |
| Agilon Health (AGL) | United States | $1.759B | 0.00 |
| PACS (PACS) | United States | $1.468B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.260B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.105B | 9.27 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.039B | 0.00 |
| CareDx (CDNA) | United States | $0.938B | 14.68 |
| Establishment Labs Holdings (ESTA) | $0.875B | 0.00 | |
| AMN Healthcare Services Inc (AMN) | United States | $0.780B | 6.17 |
| Embecta (EMBC) | United States | $0.709B | 4.86 |
| Nutex Health (NUTX) | United States | $0.608B | 11.91 |
| QDM (QDMI) | Hong Kong, SAR China | $0.583B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.511B | 13.55 |
| Sonida Senior Living (SNDA) | United States | $0.438B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.423B | 0.00 |
| Enhabit (EHAB) | United States | $0.405B | 38.05 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.369B | 0.00 |
| SBC Medicals (SBC) | United States | $0.331B | 0.00 |
| LifeMD (LFMD) | United States | $0.324B | 0.00 |
| DocGo (DCGO) | United States | $0.227B | 9.29 |
| Oncology Institute (TOI) | United States | $0.187B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.185B | 0.00 |
| Beauty Health (SKIN) | United States | $0.124B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.111B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.092B | 0.00 |
| OncoCyte (OCX) | United States | $0.088B | 0.00 |
| So-Young (SY) | China | $0.084B | 0.00 |
| Biodesix (BDSX) | United States | $0.078B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.075B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.070B | 0.00 |
| NeueHealth (NEUE) | United States | $0.057B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.021B | 0.00 |
| ModivCare (MODV) | United States | $0.017B | 5.95 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| KindlyMD (KDLY) | United States | $0.011B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |